Go-repressor proteins mediate transcriptional repression by nuclear recepto
rs in the absence of ligand. The identification of a co-repressor-receptor
interaction motif, and the finding that corepressors and co-activators comp
ete for the same site on the receptor, suggests a simple mechanism for the
switch from repression to activation upon ligand binding. Defects in this m
echanism result in dominant-negative receptors that repress transcription.
Such receptors have been implicated in several clinically important disease
s, including thyroid hormone resistance and diabetes mellitus.